FIGS: Trina Spear and Heather Hasson. The $2.5 Billion Scrubs Brand That Investors Said Would Never Work

Source note Episode guide Original audio

Summary

This How I Built This episode features Guy Raz interviewing Heather Hasson and Trina Spear about turning FIGS from car-trunk scrub sales into a profitable public healthcare-apparel company. Their account connects direct observation of clinicians, Technical Comfort, complementary founder roles, End-User-Purchased Workwear, manufacturing relationships, hundreds of investor rejections, founder control, litigation, pandemic response, and an IPO. Its central synthesis is that an overlooked professional uniform became a consumer brand when the founders treated healthcare workers as users with technical, aesthetic, and community needs rather than as a captive institutional market.

Key Claims

  • Heather’s earlier fashion work, charitable uniform project in Kenya, clinic observations, and tailoring requests from clinicians led her to identify medical scrubs as an overlooked product category.
  • Trina researched the category for roughly six months and saw a mandatory, replenishment-driven, non-seasonal market in which the source says 85% of healthcare professionals bought their own uniforms.
  • Selling outside emergency rooms let the founders validate demand and learn directly about fit, pockets, tool storage, fabric, and comfort before scaling.
  • Technical Comfort combined stretch, softness, functional details, gender-specific fit, and more deliberate colors into a product position centered on clinical work.
  • End-User-Purchased Workwear explains why hospital procurement produced little traction while direct sales to clinicians and workplace word of mouth became effective.
  • The founders say distributor and licensing savings let FIGS spend roughly twice as much on production while pricing only 15% to 20% above conventional competitors.
  • Heather led product and manufacturing development while Trina led operations and fundraising; they accepted unequal equity based on the company’s pre-partnership history without allowing stake comparison to dominate the relationship.
  • After an estimated 300 to 400 investor rejections, FIGS raised staged rounds totaling about $10 million before Thomas Tull consolidated the investor base and left the founders with two of three board seats.
  • The source reports revenue growing from about $1 million in 2015 to $263 million in 2020, with profitability reached by 2017, but these figures are not independently audited within the episode summary.
  • Strategic Partners (Medical Apparel) sued FIGS in 2019; FIGS says it spent about $40 million defending the case before a jury ruled in its favor in early 2022.
  • FIGS shifted supply relationships toward masks and protective equipment during COVID-19, then went public in May 2021 with healthcare professionals participating in the New York Stock Exchange / 纽约证券交易所 ceremony.
  • The founders use FIGS’s changing market valuation to distinguish company price and paper wealth from personal worth, while treating profitability as the prerequisite for philanthropy and advocacy.

Key Quotes

“technical comfort” — Heather’s term for combining functional performance with softness, fit, and design.

“fast noes” — the founders’ preference for quick investor rejection over prolonged uncertainty.

Connections

Contradictions

  • No settled contradiction with existing wiki content is adopted. Market size, self-purchase share, fundraising counts, production economics, revenue, valuation, legal cost, active-customer count, and global healthcare-worker estimates remain source-scoped to the founders and host framing.
  • The episode largely presents the founders’ perspective and gives limited independent detail on later operating challenges, competition, financial tradeoffs, the litigation record, or post-IPO performance.